Pune, India

Rajen Dhirubhai Shah

USPTO Granted Patents = 2 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rajen Dhirubhai Shah: Innovator in Pharmaceutical Formulations

Introduction

Rajen Dhirubhai Shah is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents to his name, Shah's work focuses on improving therapeutic delivery systems.

Latest Patents

Shah's latest patents include a nicotine-containing formulation and controlled release oral compositions comprising rivastigmine. The nicotine-containing formulation is a solid oral transmucosal dosage form that includes a therapeutically effective amount of nicotine polacrilex, citric acid monohydrate, sucrose, and liquid glucose. This dosage form is preferably designed as a lozenge. The controlled release oral compositions are pharmaceutical formulations capable of releasing a therapeutically effective dose of rivastigmine in a time-controlled manner.

Career Highlights

Throughout his career, Rajen Dhirubhai Shah has worked with prominent companies in the pharmaceutical industry, including Novartis AG and J.B. Chemicals and Pharmaceuticals Limited. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Shah has collaborated with notable professionals in the field, including Jörg Ogorka and Oskar Michael Kalb. These collaborations have further enhanced his innovative capabilities and contributed to the success of his projects.

Conclusion

Rajen Dhirubhai Shah is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact. His innovative approaches to drug delivery continue to advance the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…